The global immunosuppressive drug market is anticipated to grow at a considerable CAGR of 14.2% during the forecast period. The immunosuppressive drug is used to slow down the response of the immune system so that the organ does not get rejected by the body. The drug prevents the transplanted organ from getting damaged by the body.
The market growth is mainly attributed to the increasing transplant due to organ failure across the globe. Many people need organ transplants due to various factors such as damage of organs due to chronic diseases for instance diabetes, various types of infections such as hepatitis. Moreover, physical injuries to organs and genetic conditions such as heart defect, kidney disease are other causes for organ transplant and which requires immunosuppressive drug in the later stages of treatment. As per Health Resource and Service Administration, around 39,000 transplants were performed in 2020 in the US. However, there were more than 107,000 people including children were in waiting for organ transplants in the US. It represents a significant gap in the supply and demand of organ transplants even in the developed economies.
However, as immunosuppressive drug have its advantage as well as it has some disadvantages also such as it diminish the strength of the immune system of the human body that results in lowering the detecting and fighting power of immune system from cancer cells which is a restrictive factor for the market growth.
To Request a Sample of our Report on Immunosuppressive Drug Market: https://www.omrglobal.com/request-sample/immunosuppressive-drug-market
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
Segment Covered-
- By Application
- By Drug Type
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– AbbVie, Inc., Bristol-Myers Squibb Co., Novartis AG, Pfizer, Inc., Sanofi SA
Immunosuppressive Drug Market Report Segment
By Application
- Heart Transplant
- Kidney Transplant
- Liver Transplant
- Lungs Transplant
- Other
By Drug Class
- Calcineurin Inhibitor
- Antiproliferative Agent
- Motor Inhibitors
- Steroids
- Other
By Drug Type
- Patented
- Generic
A full Report of Immunosuppressive Drug Market is Available @ https://www.omrglobal.com/industry-reports/immunosuppressive-drug-market
Immunosuppressive Drug Market Report Segment by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Company Profiles
- Abbvie Inc.
- Astellas Pharma Inc
- Biocon Ltd.
- Bristol-Myers Squibb Co.
- Cadila Healthcare Ltd.
- Reddy’s Laboratories Ltd.
- Hoffmann-La Roche Ltd.
- Intas Pharmaceuticals Ltd (Accord Healthcare Ltd.)
- LGM Pharma, LLC
- Mylan NV
- Novartis AG (Sandoz)
- Pfizer Inc.
- Sanofi SA
- Taj Pharmaceuticals Ltd.
- Topas Therapeutics GmbH
- Teva Pharmaceutical Industries Ltd.
- Veloxis Pharmaceuticals, Inc.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/immunosuppressive-drug-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
